• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1070350-48
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Perforation (2001); Ventricular Tachycardia (2132)
Event Date 12/15/2016
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: stent: xience xpedition: 2.5 x 15, 3.0 x 33, 3.5 x 48 and 4.0 x 18 , graftmaster 3.5 x 19.The device was not returned for evaluation.The reported patient effects of death, hypotension, perforation, and ventricular tachycardia are listed in the xience xpedition everolimus eluting coronary stent system instructions for use as known patient effects of coronary stenting procedures.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported the procedure on (b)(6) 2016 was to treat a patient with acute coronary syndrome (acs).Two xience xpedition stents (2.5x15 mm, 3.0x33 mm) were implanted in the mid left anterior descending (lad) artery.After the procedure, the patient suffered from chest pain and cold sweating; therefore, intravascular ultrasound (ivus) was performed which confirmed that the xience xpedition stents were well deployed; however, the proximal right coronary artery (rca) was noted to be occluded without flow.There was faint collateral artery from the lad apex to the rca.Ventricular fibrillation occurred twice while angiogram was performed which was stabilized after intra-aortic balloon pump and a temporary pacemaker as well as closely monitoring in the icu.Post diagnosis revealed the mid rca to rca/posterior descending artery (pda) with stenosis and dissection spontaneously with timi 3.Ivus revealed a large rca vessel dissection from the mid to distal rca and hematoma.On (b)(6) 2016, three xience xpeditions (3.5x48 mm (x2), 4.0x18 mm) were implanted in the rca.Ivus revealed a perforation occurred at the mid rca where the 3.5x48 mm stent was implanted.A 3.5x19 mm graftmaster was implanted to seal the perforation.Bedside echocardiography revealed small amount of pericardial effusion so pericardiocentesis was performed.The lesion was checked by ivus and post-dilatation was performed.Blood pressure dropped, tachycardia and cardiac arrest occurred.The patient was given medication and cpr was performed.The patient subsequently died on (b)(6) /2016 with right ventricular dysfunction and failure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6238704
MDR Text Key64389655
Report Number2024168-2017-00270
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648158346
UDI-Public(01)08717648158346(17)190829(10)6082241
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 01/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/29/2019
Device Catalogue Number1070350-48
Device Lot Number6082241
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/19/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age63 YR
-
-